ANXA2 and head and neck cancer: The down-regulation of annexin A2 has been implicated in head and neck cancers primarily in esophageal squamous cell carcinoma (ESCC), nasopharyngeal carcinoma (NPC), and head and neck squamous cell carcinoma (HNSCC).